Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 280

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 280
---
ion Purchase Agreement) and a further option to increase to Five Hundred Million Dollars ($500,000,000) after Two Hundred and Fifty
Million Dollars ($250,000,000) has been issued and sold to White Lion under the White Lion Purchase Agreement, subject to certain limitations
and conditions set forth in the White Lion Purchase Agreement. The White Lion Purchase Agreement was included as Exhibit 10.27 of the
Form F-1 registration statement filed on December 5, 2024.

On December 10, 2024, 35,000 Class A Ordinary
Shares were issued to White Lion amounting $276,850, in consideration for White Lion’s commitment pursuant to the White Lion Purchase
Agreement. In addition, on December 12, 2024, pursuant to this Agreement, the Company issued 9,500 Class A Ordinary Shares for a purchase
price of $1,572,186. On December 24, 2024, the Company issued 25,000 Class A Ordinary Shares for a purchase price of $160,050. On December
31, 2024, the Company issued 30,000 Class A Ordinary Shares for a purchase price of $204,000.

Note 3: Upon de-spac business combination, additional
paid-in capital and capital reserve of Legacy NewGenIvf was combined with additional paid-in capital and accumulated net losses of the
A SPAC I Acquisition Corp and added into the additional paid-in capital of NewGenIvf Group upon the reverse take-over.

Note 4: Referring to note 1, this is part of
the subscription receivable as of December 31, 2024, represented the founders’ subscribed shares on the share entitled upon the
business combination at April 3 2024 and it had been capitalized as part to the additional paid-in capital.

<div align='center'>F-56</div>

Note 5: During the six months period June 30,
2025, the Company had issued 1,109,300 shares after taking account of the reverse stock split on Feb 11, 2025 and May 6, 2025 respectively.

Note 6: The Company had issued 125,000 ordinary
shares valued at US$2.06 per share for acquiring of MicroSort Reproductive Technology on January 21, 2025.

NOTE 13 — EMPLOYEE BENEFIT PLANS

HK SAR

The Company has a defined
contribution pension scheme for